Health
Researchers test novel gene regulation approach to treat brain diseases – News-Medical.Net
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation…
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer’s in laboratory studies. It leverages zinc finger proteins, which specifically bind to the DNA that codes for the protein Tau without altering it, thereby reducing Tau production in the brain and preventing nerve damage. The preclinical results, published in the journal Science Advances,…
-
General14 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General18 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News22 hours agoWave of cruises headed for Sunshine Coast this summer
-
General22 hours agoOlder Australians struggling to find work before hitting the pension age